This protocol is judged by an institutional evaluation board, an impartial group that reviews any clinical trials involving human beings. If a research entails a Routine I drug, after the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) quantity through the FDA.“It’s importa